Kansas, South Carolina, Wisconsin, Wyoming, Idaho and Tennessee are the states most likely to legalize medical cannabis next, while Nebraska works through litigation and a legislative rewrite of the program voters approved in 2024. In almost every case, the debate has shifted from whether cannabis helps patients to how quickly and easily a state can deliver it. Convenience, not ideology, now decides which bills move.

Cannabis Legalization Next States List: Has Convenience Become the Deciding Factor?

Which states are most likely to legalize medical cannabis next?

Kansas sits closest of the states with no program at all. Committees in both chambers have advanced medical cannabis bills in recent sessions, and the governor has signaled support, but law enforcement groups have blocked a floor vote.

Will Texas Legalize Cannabis Next?

South Carolina's Senate has repeatedly passed a Compassionate Care Act, only to see the House decline to take it up. Wisconsin's Assembly approved a narrow medical bill limited to oils and pills, and the Senate never acted. Both states return to the same fight each session with slightly broader language.

Cannabis Legalization 2026: Upcoming States and the Shift Towards Convenience

Wyoming and Idaho depend on the ballot rather than the legislature. Idaho remains one of the few states with no medical cannabis law, and organizers there are collecting signatures for a citizen initiative. Wyoming lawmakers have declined to move bills, leaving advocates to pursue a statewide vote.

read more

Tennessee already allows a low-THC oil for intractable seizures, a program so narrow that patients often cannot fill a prescription within driving distance. Expansion bills surface yearly, and the state's limited status makes it a frequent candidate for a broader law.

How has convenience become the deciding factor in cannabis policy?

Patients do not shop for the most generous statute. They enroll where certification is fast, dispensaries are near, and the product they need is in stock. Lawmakers have noticed that programs with telehealth renewals and reasonable store counts show higher patient registration than programs with strict limits.

That comparison pressures holdout states. A bill that legalizes cannabis but caps dispensaries at a handful or bans flower creates the same complaint legislators hear from patients now: it is legal on paper and useless in practice.

What convenience features show up in newer laws?

  • Telehealth certification and renewal, so patients avoid multiple clinic trips
  • Home delivery, especially for rural counties without a nearby dispensary
  • Dispensary counts tied to patient population rather than a fixed low number
  • Reciprocity for out-of-state patient cards
  • Realistic possession limits and a full range of product forms

What about states that already allow medical cannabis but limit access?

Texas, Georgia, Alabama and Kentucky all permit medical cannabis in some form, yet each restricts who can prescribe it, what conditions qualify, or how many dispensaries may open. Patients in those states report drives of two hours or more to reach a pharmacy, which pushes expansion debates back onto the floor.

This is where convenience becomes measurable. When a state adds qualifying conditions or licenses more dispensaries, enrollment climbs in the following year. When it keeps a low THC cap or a short list of conditions, enrollment stalls even though the law exists.

What should patients and advocates watch in pending bills?

  1. Qualifying conditions list and whether a physician or nurse practitioner can certify
  2. Dispensary caps, delivery rules and zoning restrictions
  3. Timelines for issuing patient cards and licensing businesses
  4. Taxes on medical sales, which affect final patient cost

Public opinion is not the obstacle. About 88% of US adults support legal marijuana for medical use, so the remaining fights are about program mechanics. States that write convenience into the law from day one will enroll patients fastest and face the fewest fix-it bills later.